Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Biogen Idec's long-acting beta interferon moves ahead in MS
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Receptos to deliver scientific presentations about RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.
Thrombotic microangiopathy associated with interferon beta.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Determination and characterization of a cannabinoid receptor in rat brain.
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Cyclophosphamide
Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.

Pages